Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry

Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry

Resource Type

CF Research News

Authors

Sigal Kaplan, Andrew Lee, Noreen Caine, Susan C Charman, Diana Bilton

References

J Cyst Fibros. 2020 Aug 14;S1569-1993(20)30816-X. doi: 10.1016/j.jcf.2020.08.001. Online ahead of print.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Colistimethate sodium dry powder for inhalation [3]
Colobreathe [4]
Long-term safety [5]
UK Cystic Fibrosis Registry [6]

Date

Friday, August 14, 2020

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/long-term-safety-study-colistimethate-sodium-colobreathe%C2%AE-findings

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-20-00212R1_FINAL_Kaplan_180121.pdf [2] https://pubmed.ncbi.nlm.nih.gov/32807645/ [3] https://www.ecfs.eu/research-article-keywords/colistimethate-sodium-dry-powder-inhalation [4] https://www.ecfs.eu/research-article-keywords/colobreathe [5] https://www.ecfs.eu/research-article-keywords/long-term-safety [6] https://www.ecfs.eu/research-article-keywords/uk-cystic-fibrosis-registry [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines